Bioserenity is listed on the portfolio pages of Eurazeo (portfolio page) and LBO France (portfolio page). Eurazeo and LBO France list it as current. Eurazeo has owned Bioserenity since 2019, per Eurazeo's portfolio page.
Bioserenity is a Healthcare company. Its owner on record, Eurazeo, is a buyout firm founded in 2001, headquartered in Paris, France, with €35 billion under management. Eurazeo lists 266 companies in the index, 34 of them in Healthcare. Also backed by LBO France.
Eurazeo is a leading French private equity firm and investment group that manages a diversified portfolio of over 600 companies.
Read the Eurazeo profileLBO France is a multi-asset investment platform that takes minority or majority stakes in companies with values between 20 and 300 million euros.
Read the LBO France profileBioserenity is listed on the portfolio pages of Eurazeo (portfolio page) and LBO France (portfolio page). Eurazeo and LBO France list it as current. Eurazeo has owned Bioserenity since 2019, per Eurazeo's portfolio page.
Bioserenity is in Healthcare. Classified from the owner's portfolio label.
Eurazeo is headquartered in Paris, France.
Eurazeo lists 33 other Healthcare companies in the index, including 3P Biopharmaceuticals, Amolyt Pharma, C2S, Cardiologs Technologies and Cranial Technologies.
6 of 265 shown
See the full Eurazeo portfolio.
6 of 100 shown
See the full LBO France portfolio.
Browse PE-backed companies.
